Pharmaceutical Investing

Propanc Biopharma Receives Patent for Cancer Treatment in China

Pharmaceutical Investing

PetLife Pharmaceuticals' CEO Issues Letter to Shareholders

Pharmaceutical Investing

UroGen Gets $7.5 Million Payment from Licensing Agreement

Pharmaceutical Investing

Opiant Pharmaceuticals Announces Phase I Data for OPNT002

Pharmaceutical Investing

BriaCell Provides Clinical Update on Ongoing Study of BriaVax

Biotech Investing

Kura Oncology Gets US Patent for Tipifarnib in Head and Neck Cancer

Pharmaceutical Investing

ESSA Pharma Updates Proposed Equity Offering

Pharmaceutical Investing

Propanc Biopharma Announces Joint Research Partnership with Jaen University

Pharmaceutical Investing

Moleculin Signs Agreement with MD Anderson Cancer Center

Pharmaceutical Investing

DelMar Pharmaceuticals Announces Completion of First Site Initiation Visit for STAR-3 Pivotal Phase 3 Clinical Trial of VAL-083 in Refractory GBM

Pharmaceutical Investing

Medicenna Appoints New Chief Scientific Officer

Pharmaceutical Investing

Cardiome Shares Health Canada Approval of AGGRASTAT

Pharmaceutical Investing

Latest pharmaceutical News

More pharmaceutical News

Outlook Reports world

Resource
Tech
Life Science

Browse Companies

Resource
Tech
Life Science
MARKETS
COMMODITIES
CURRENCIES